Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Jessica Mathews

CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid downsizing’ of consumer business

zoomed-in photo of ozempic drug packaging next to a portrait of a woman smiling (Credit: Carsten Snejbjerg—Bloomberg/Getty Images; Calibrate)

Calibrate, the weight-loss startup backed by Founders Fund and Tiger Global, is making changes to its management team as investors restructure the company, according to an investor letter and internal correspondence seen by Fortune, as well as another person familiar with the changes. 

Calibrate’s founder and chief executive, Isabelle Kenyon, is stepping down as CEO and will no longer oversee day-to-day operations, she confirmed in a Slack message sent to employees Monday afternoon that was seen by Fortune. In the note, she stated she would be staying with the company as “founder.” Calibrate CFO Dave Fielding will also step down, according to someone familiar with the matter. Potential replacements for both those roles are being interviewed, the person says. Calibrate executives Scott Honken and Ed Cudahy have been promoted to oversee day-to-day operations and will report directly to the board, according to Kenyon’s Slack message.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.